Lack of response suppression follows repeated ventral tegmental cannabinoid administration: an in vitro electrophysiological study

scientific article

Lack of response suppression follows repeated ventral tegmental cannabinoid administration: an in vitro electrophysiological study is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/S0306-4522(00)00241-4
P698PubMed publication ID10974429

P2093author name stringR Mason
D A Kendall
C A Marsden
J F Cheer
P2860cites workPresynaptically located CB1 cannabinoid receptors regulate GABA release from axon terminals of specific hippocampal interneuronsQ28144567
Structure of a cannabinoid receptor and functional expression of the cloned cDNAQ28240076
Cannabinoids inhibit N- and P/Q-type calcium channels in cultured rat hippocampal neuronsQ28245016
Cannabinoid CB(1) receptors colocalize with tyrosine hydroxylase in cultured fetal mesencephalic neurons and their activation increases the levels of this enzymeQ28372132
Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic studyQ29615905
The dopamine hypothesis of reward: past and current statusQ33756130
SR141716A, a potent and selective antagonist of the brain cannabinoid receptorQ34332716
Mesolimbic dopaminergic decline after cannabinoid withdrawalQ34750833
Dopamine-containing neurons in the mammalian central nervous system: electrophysiology and pharmacologyQ39643228
Synaptic regulation of mesocorticolimbic dopamine neuronsQ41132697
SR141716A is an inverse agonist at the human cannabinoid CB1 receptorQ42445979
Localization of cannabinoid receptor mRNA in rat brainQ42510202
delta9-Tetrahydrocannabinol excites rat VTA dopamine neurons through activation of cannabinoid CB1 but not opioid receptorsQ44345904
Δ9-Tetrahydrocannabinol alters cerebral metabolism in a biphasic, dose-dependent mannier in rat brainQ44491492
Electrophysiological characterization of GABAergic neurons in the ventral tegmental area.Q46383884
SR 141716A, a cannabinoid receptor antagonist, produces hyperalgesia in untreated miceQ47628019
Cannabinoid transmission and reward-related eventsQ48285165
Heterogeneity of ventral tegmental area neurons: single-unit recording and iontophoresis in awake, unrestrained ratsQ48422397
Presynaptic inhibition of GABAergic inputs to rat substantia nigra pars reticulata neurones by a cannabinoid agonistQ48484213
Cannabinoids activate mesolimbic dopamine neurons by an action on cannabinoid CB1 receptorsQ48518726
Opioids excite dopamine neurons by hyperpolarization of local interneuronsQ48543154
The projections of the ventral tegmental area and adjacent regions: a combined fluorescent retrograde tracer and immunofluorescence study in the rat.Q50933545
Protein kinase C disrupts cannabinoid actions by phosphorylation of the CB1 cannabinoid receptor.Q52529851
Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activityQ64386018
A subpopulation of mesencephalic dopamine neurons projecting to limbic areas contains a cholecystokinin-like peptide: evidence from immunohistochemistry combined with retrograde tracingQ67270148
The effects of delta 9-tetrahydrocannabinol on potassium-evoked release of dopamine in the rat caudate nucleus: an in vivo electrochemical and in vivo microdialysis studyQ69853528
Cannabinoid receptor stimulation of guanosine-5'-O-(3-[35S]thio)triphosphate binding in rat brain membranesQ71407604
Neurotransmitter regulation of dopamine neurons in the ventral tegmental areaQ72215317
L-glutamate excitation of A10 dopamine neurons is preferentially mediated by activation of NMDA receptors: extra- and intracellular electrophysiological studies in brain slicesQ72666284
Effects of chronic delta9-tetrahydrocannabinol on rat midbrain dopamine neurons: an electrophysiological assessmentQ73500317
P433issue4
P407language of work or nameEnglishQ1860
P921main subjectelectrophysiologyQ1154774
cannabinoidsQ422936
P304page(s)661-667
P577publication date2000-01-01
P1433published inNeuroscienceQ15708571
P1476titleLack of response suppression follows repeated ventral tegmental cannabinoid administration: an in vitro electrophysiological study
P478volume99

Reverse relations

cites work (P2860)
Q38036236A brain on cannabinoids: the role of dopamine release in reward seeking
Q34676610Beyond the CB1 Receptor: Is Cannabidiol the Answer for Disorders of Motivation?
Q37760048Cannabinoid conditioned reward and aversion: behavioral and neural processes.
Q37734568Cannabinoid-dopamine interaction in the pathophysiology and treatment of CNS disorders.
Q44298237Cannabinoid-induced Fos expression within A10 dopaminergic neurons
Q36393644Cannabinoids and value-based decision making: implications for neurodegenerative disorders.
Q44885114Cannabinoids enhance subsecond dopamine release in the nucleus accumbens of awake rats.
Q44666878Cannabinoids modulate ultrasound-induced aversive responses in rats
Q30807024Cannabinoids: reward, dependence, and underlying neurochemical mechanisms--a review of recent preclinical data
Q62725703Delta-9-tetrahydrocannabinol increases striatal glutamate levels in healthy individuals: implications for psychosis
Q44385248Differential cannabinoid-induced electrophysiological effects in rat ventral tegmentum
Q44830723Differential effects of acute cannabinoid drug treatment, mediated by CB1 receptors, on the in vivo activity of tyrosine and tryptophan hydroxylase in the rat brain
Q28297001Disruption of PTEN coupling with 5-HT2C receptors suppresses behavioral responses induced by drugs of abuse
Q36201313Effect of CB1 receptor blockade on food-reinforced responding and associated nucleus accumbens neuronal activity in rats
Q44563666Effects of direct periaqueductal grey administration of a cannabinoid receptor agonist on nociceptive and aversive responses in rats
Q47319226Endocannabinoid Actions on Cortical Terminals Orchestrate Local Modulation of Dopamine Release in the Nucleus Accumbens
Q39400299Endocannabinoid Regulation of Reward and Reinforcement through Interaction with Dopamine and Endogenous Opioid Signaling
Q38250054Endocannabinoid-dependent modulation of phasic dopamine signaling encodes external and internal reward-predictive cues
Q36452302Identification of the sites of 2-arachidonoylglycerol synthesis and action imply retrograde endocannabinoid signaling at both GABAergic and glutamatergic synapses in the ventral tegmental area.
Q33645739Individual and additive effects of the CNR1 and FAAH genes on brain response to marijuana cues.
Q44051647Inhibition of GABAergic neurotransmission in the ventral tegmental area by cannabinoids
Q44048463Inhibition of methamphetamine self-administration in rats by cannabinoid receptor antagonist AM 251.
Q24671514Marijuana and cannabinoid regulation of brain reward circuits
Q34430714Modulation of transmitter release via presynaptic cannabinoid receptors
Q48273958Neurosystems linking corticolimbic and hypothalamic pathways in energy balance: view from the Chair
Q96953338One Is Not Enough: Understanding and Modeling Polysubstance Use
Q35779281Phasic D1 and tonic D2 dopamine receptor signaling double dissociate the motivational effects of acute nicotine and chronic nicotine withdrawal
Q37226537Prejunctional and peripheral effects of the cannabinoid CB(1) receptor inverse agonist rimonabant (SR 141716).
Q46504765Prenatal Ethanol Exposure Persistently Alters Endocannabinoid Signaling and Endocannabinoid-Mediated Excitatory Synaptic Plasticity in Ventral Tegmental Area Dopamine Neurons.
Q38126265Tales from the dark side: do neuromodulators of drug withdrawal require changes in endocannabinoid tone?
Q64229781The Endocannabinoid System and Cannabidiol's Promise for the Treatment of Substance Use Disorder
Q42485353The endocannabinoid 2-arachidonoylglycerol inhibits long-term potentiation of glutamatergic synapses onto ventral tegmental area dopamine neurons in mice
Q24648473The endocannabinoid system as an emerging target of pharmacotherapy
Q26770739To Act or Not to Act: Endocannabinoid/Dopamine Interactions in Decision-Making
Q38044684Using dopamine research to generate rational cannabinoid drug policy

Search more.